We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPL
8601
DELISTED
Great Panther Mining Limited
GPL
$60K ﹤0.01%
7,072
+3,708
+110% +$36.7K
CLDX icon
8602
Celldex Therapeutics
CLDX
$3.23B
$59K ﹤0.01%
8,635
-12,307
-59% -$86.2K
DSX icon
8603
CALL
Diana Shipping
DSX
$309M
$59K ﹤0.01%
+20,454
New +$61.1K
CCLP
8604
PUT
DELISTED
CSI Compressco LP
CCLP
$59K ﹤0.01%
11,400
-4,400
-28% -$24.9K
GEN
8605
DELISTED
Genesis Healthcare, Inc.
GEN
$59K ﹤0.01%
43,426
-8,956
-17% -$14.2K
HYRE
8606
DELISTED
HyreCar Inc. Common Stock
HYRE
$58K ﹤0.01%
22,790
-3,565
-14% -$12.4K
ASCMA
8607
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$58K ﹤0.01%
32,939
+13,468
+69% +$34.6K
DRD
8608
DRDGold
DRD
$2.1B
$57K ﹤0.01%
+23,567
New +$54K
IMNN icon
8609
CALL
Imunon
IMNN
$6.93M
$57K ﹤0.01%
105
+28
+36% +$15.4K
MVIS icon
8610
Microvision
MVIS
$52.3M
$57K ﹤0.01%
3,146
-434
-12% -$6.8K
VRDN icon
8611
Viridian Therapeutics
VRDN
$2.49B
$57K ﹤0.01%
+683
New +$64.4K
TMBR
8612
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$57K ﹤0.01%
20
-2
-9% -$5.78K
BDSI
8613
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$57K ﹤0.01%
20,400
+4,600
+29% +$12.9K
KA
8614
DELISTED
Kineta, Inc. Common Stock
KA
$56K ﹤0.01%
166
-337
-67% -$120K
TEUM
8615
DELISTED
Pareteum Corporation
TEUM
$56K ﹤0.01%
+18,507
New +$49.9K
JAKK icon
8616
Jakks Pacific
JAKK
$290M
$55K ﹤0.01%
2,148
-319
-13% -$8.03K
MIN
8617
Aberdeen Intermediate Income Fund
MIN
$280M
$55K ﹤0.01%
14,582
-19,556
-57% -$74.3K
NAK
8618
PUT
Northern Dynasty Minerals
NAK
$919M
$55K ﹤0.01%
98,500
-19,600
-17% -$10.6K
AUTO
8619
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$55K ﹤0.01%
18,692
+1,765
+10% +$6.49K
CORV
8620
PUT
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$55K ﹤0.01%
+13,600
New +$60K
SSI
8621
DELISTED
Stage Stores Inc
SSI
$55K ﹤0.01%
27,972
-9,999
-26% -$21.4K
STON
8622
PUT
DELISTED
StoneMor Inc.
STON
$54K ﹤0.01%
10,500
-15,100
-59% -$69.1K
MN
8623
PUT
DELISTED
MANNING & NAPIER, INC.
MN
$54K ﹤0.01%
+18,300
New +$52.9K
ZSAN
8624
DELISTED
Zosano Pharma Corporation
ZSAN
$54K ﹤0.01%
+378
New +$55.4K
FSNN
8625
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$54K ﹤0.01%
+21,159
New +$78.9K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.